|
FY2025
12 months to Dec 31, 2025
|
FY2024
9 months to Dec 31, 2024
|
FY2023
12 months to Mar 31, 2024
|
FY2022
12 months to Mar 31, 2023
|
FY2021
12 months to Mar 31, 2022
|
|
|---|---|---|---|---|---|
| Operating activities | |||||
| Net loss | |||||
| Items not affecting cash: | |||||
| Amortization of property, plant and equipment and intangible assets | |||||
| Depreciation of property, plant and equipment and intangible assets | |||||
| Deferred income tax expense | |||||
| Pension funding in excess of expense | |||||
| Post-employment benefit funding in excess of expense | |||||
| Unrealized foreign exchange gain on: | |||||
| accrued pension liability | |||||
| post-employment benefit obligations | |||||
| Finance costs | |||||
| Severance costs | |||||
| Loss on disposal of property, plant and equipment | |||||
| Interest on pension and other post-employment benefit obligations | |||||
| Interest on finance lease | |||||
| Other income | |||||
| Accretion of governmental loans and environmental liabilities | |||||
| Unrealized foreign exchange gain on government loan facilities | |||||
| (Decrease) increase in fair value of IPO and LETL Warrant liabilities | |||||
| (Decrease) increase in fair value of earnout liability | |||||
| (Decrease) increase in fair value of share-based payment compensation liability | |||||
| Listing expense | |||||
| Impairment loss | |||||
| Other | |||||
| Adjustments to reconcile profit (loss) | |||||
| Cash flows from (used in) operations | |||||
| Net change in non-cash operating working capital | |||||
| Share-based payment compensation and earnout units settled | |||||
| Environmental liabilities paid | |||||
| Insurance proceeds for operating expenses | |||||
| Cash (used in) generated by operating activities | |||||
| Investing activities | |||||
| Acquisition of property, plant and equipment | |||||
| Acquisition of right-of-use assets | |||||
| Issuance of related party receivable | |||||
| Insurance proceeds for property damage | |||||
| Proceeds from land sale | |||||
| Cash used in investing activities | |||||
| Financing activities | |||||
| Bank indebtedness advanced, net | |||||
| Repayment of term loans | |||||
| Transaction costs on bank indebtedness | |||||
| Restricted cash | |||||
| Senior secured lien notes issued, net of underwriter fees | |||||
| Transaction costs on senior secured lien notes | |||||
| Governmental loans benefit on below-market rate of interest loans | |||||
| Governmental loans received | |||||
| Governmental loans transaction costs | |||||
| Repayment of governmental loans | |||||
| Interest paid | |||||
| Proceeds from issuance of shares | |||||
| Dividends paid | |||||
| Common shares repurchased and cancelled | |||||
| Other | |||||
| Cash generated by financing activities | |||||
| Effect of exchange rate changes on cash | |||||
| Cash | |||||
| (Decrease) increase in cash | |||||
| Opening balance | |||||
| Ending balance | |||||
Loading...